Definition of Biosimilars. Meaning of Biosimilars. Synonyms of Biosimilars

Here you will find one or more explanations in English for the word Biosimilars. Also in the bottom left of the page several parts of wikipedia pages related to the word Biosimilars and, of course, Biosimilars synonyms and on the right images related to the word Biosimilars.

Definition of Biosimilars

No result for Biosimilars. Showing similar results...

Meaning of Biosimilars from wikipedia

- for evaluating biosimilars. The EMA has granted marketing authorizations for more than 50 biosimilars since 2006. The first biosimilar of a monoclonal...
- Union. In 2018, the biosimilars Halimatoz, Hefiya, Hyrimoz, and Hulio were approved for use in the European Union. Adalimumab biosimilars became available...
- States in 1998, and in the European Union in August 1999. Infliximab biosimilars have been approved in the EU (2013), in ****an (2014), and in the United...
- follow-on biosimilars will exhibit variability in specific variants over time. The safety and clinical performance of both originator and biosimilar biopharmaceuticals...
- Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was...
- original on 7 June 2016. Retrieved 9 June 2016. "Biosimilars of Rituximab". Generics and Biosimilars Initiative. 14 April 2017. Archived from the original...
- launches biosimilar in EU". Business Standard. Retrieved 17 August 2023. "Dr Reddy's looks to biosimilars for growth". Generics and Biosimilars Initiative...
- Center for Biosimilars®". "Biosimilars and Interchangeable Biologics: Tactical Elements". "Fundamentals of Modern Bioprocessing". "Biosimilarity: The FDA...
- Act of 2009) do have in place a system to approve generic biologics (biosimilars) which "requires mandatory clinical testing and periodic review". In...
- Kaszkin-Bettag M (2013). "Safety and toxicity of biosimilars—EU versus US regulation". Generics and Biosimilars Initiative Journal. 2 (3): 144–150. doi:10.5639/gabij...